Both in Pharmaceuticals
Evolus vs Arvinas
Over the past year EOLS returned +18.6% and ARVN returned −24.0%; their daily moves had a correlation of 0.29.
EOLS +18.6% ARVN −24.0%Growth of $1, one year, split-adjusted
| Metric | EOLS | ARVN |
|---|---|---|
| Price | $7.58 | $7.39 |
| Market cap | $500.7M | $483.2M |
| Today | +2.85% | +4.23% |
| 1 month | +2.7% | +1.1% |
| 6 months | +19.9% | −28.0% |
| Year to date | +14.0% | −37.7% |
| 1 year | +18.6% | −24.0% |
| Revenue growth (YoY) | +21.2% | +1014.7% |
| Gross margin | 68.0% | 96.4% |
| Net margin | −9.6% | 67.8% |
| P/E (TTM) | — | 52.0× |
| Price / sales | 1.6× | 1.5× |
| Net cash | -$141.9M | $567.6M |
| Dividend yield | — | — |
| Volatility (60d) | 49.2% | 49.2% |
| Short % of float | 12.2% | 10.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).